Majority of biotech companies completing an IPO from 1997-2016 achieved product approvals
E-Mail IMAGE: Estimated probability (Kaplan-Meier) of a company with IPO from 1997-2016 having at least one product approved by year after IPO for small molecules versus biologicals. view more Credit: Center for Integration of Science and Industry, Bentley University A large scale study from Bentley University of the biotechnology companies that completed Initial Public Offerings from 1997-2016 estimates that 78% of these companies are associated with products that reach phase 3 trials and 52% are associated with new product approvals. The article, titled "Late-stage product deve...
Source: eurekalert.org